Skip to main content

Lazard Ltd Reports First-Quarter 2023 Results

First-quarter operating revenue of $527 million; AUM of $232 billion up 7% from year-end

Raymond J. McGuire joins Lazard; firm expands Restructuring practice with addition of two MDs

Cost-saving initiatives to improve profitability

Lazard Ltd (NYSE: LAZ) today reported operating revenue1 of $527 million for the quarter ended March 31, 2023. Net loss, as adjusted2, was $23 million, or $0.26 per share, diluted, for the quarter. First-quarter 2023 net loss on a U.S. GAAP basis was $22 million, or $0.27 per share, diluted.

“The first quarter was marked by economic uncertainty and market turmoil, particularly in the financial sector,” said Kenneth M. Jacobs, Chairman and Chief Executive Officer of Lazard. “Asset Management is off to a solid start for the year. However, slower M&A activity resulted in significantly lower revenues in the quarter and the outlook for the year remains uncertain. We are implementing cost-saving initiatives to right-size for the current environment and provide flexibility to strategically invest in our business.”

 

 

 

 

 

 

 

($ in millions, except

 

Quarter Ended March 31,

per share data and AUM)

 

 

 

 

 

 

 

 

 

 

 

2023

 

2022

 

%'23-'22

Net Income (Loss)

 

 

 

 

 

 

U.S. GAAP

 

($22)

 

$114

 

(119%)

Per share, diluted

 

($0.27)

 

$1.05

 

(126%)

Adjusted2

 

($23)

 

$115

 

(120%)

Per share, diluted

 

($0.26)

 

$1.05

 

(125%)

 

 

 

 

 

 

 

Operating Revenue1

 

 

 

 

 

 

Total operating revenue

 

$527

 

$699

 

(25%)

Financial Advisory

 

$274

 

$388

 

(29%)

Asset Management

 

$265

 

$312

 

(15%)

 

 

 

 

 

 

 

AUM ($ in billions)

 

 

 

 

 

 

Period end

 

$232

 

$253

 

(8%)

Average

 

$227

 

$256

 

(12%)

 

 

 

 

 

 

 

Note: Endnotes are on page 4 of this release. A reconciliation of adjusted GAAP to U.S. GAAP is on pages 10-11.

OPERATING REVENUE

Operating revenue was $527 million for the quarter ended March 31, 2023, 25% lower than the first quarter of 2022.

Financial Advisory

Our Financial Advisory results include Strategic and M&A Advisory, Capital Markets Advisory, Shareholder Advisory, Restructuring and Capital Solutions, Sovereign Advisory, Geopolitical Advisory, Capital Raising and Placement and other strategic advisory for clients.

Financial Advisory operating revenue was $274 million for the first quarter of 2023, 29% lower than the first quarter of 2022.

During and since the first quarter of 2023, Lazard has been engaged in significant and complex M&A transactions and other strategic advisory assignments globally, including the following (clients are in italics): AVEVA Group's $12.4 billion sale to Schneider Electric; CVS Health's $10.6 billion acquisition of Oak Street Health; iStar's $6.4 billion business combination with Safehold; Mars' $1.45 billion acquisition of Heska; STARK Group's £740 million acquisition of Saint-Gobain Building Distribution Ltd; Devro's £692 million acquisition by SARIA NEDERLAND B.V.; Aptean's investment from TA Associates and Insight Partners; Energy Infrastructure Partners-led consortium acquisition of a 19.85% stake in Fluxys SA; GEODIS' acquisition of trans-o-flex; Hull Street Energy's sale of Foundation Solar Partners to Birch Creek Energy; Lone Star Funds' acquisition of Titan Acquisition Holdings from Carlyle and Stellex Capital; Paradigm Precision's merger with Whitcraft Group; Sodexo on its planned spin-off and listing of its Benefits and Rewards Services unit and Vodafone's joint venture with Altice Group to deploy fibre-to-the-home in Germany to 7 million homes.

Lazard has one of the world’s preeminent restructuring and capital solutions practices. During and since the first quarter of 2023, we have been engaged in a broad range of visible and complex restructuring and debt advisory assignments, including debtor roles involving Bed Bath & Beyond, IKKS, National CineMedia, SiO2 Medical Products and Vue Entertainment, and creditor and/or related party roles involving Endo Pharmaceuticals, Orpea, Party City, Ruby Pipeline, Technicolor Creative Studio and Venator.

Our Capital Advisory practice remains active globally, advising on a broad range of public and private assignments. Our Sovereign Advisory practice continues to be active advising governments, sovereign and sub-sovereign entities across developed and emerging markets.

For a list of publicly announced Financial Advisory transactions on which Lazard advised in the first quarter of 2023, or continued to advise or completed since March 31, 2023, please visit our website at www.lazard.com/financial-advisory/transactions/.

Asset Management

In the text portion of this press release, we present our Asset Management results as 1) Management fees and other revenue, and 2) Incentive fees.

Asset Management operating revenue was $265 million for the first quarter of 2023, 15% lower than the first quarter of 2022.

Management fees and other revenue was $259 million, 10% lower than the first quarter of 2022, and 6% higher than the fourth quarter of 2022.

Average assets under management (AUM) for the first quarter of 2023 was $227 billion, 12% lower than the first quarter of 2022, and 7% higher than the fourth quarter of 2022.

AUM as of March 31, 2023 was $232 billion, 7% higher than December 31, 2022, and 8% lower than March 31, 2022. The sequential change from December 31, 2022 was driven by market appreciation of $11.6 billion, foreign exchange appreciation of $1.4 billion and net inflows of $3.0 billion, which includes approximately $3.9 billion related to a wealth management acquisition.

Incentive fees during the period were $5 million, compared to $25 million for the first quarter of 2022.

Corporate Activity and Cost-Saving Initiatives

Corporate net revenues were a loss of $11 million, on an adjusted basis, including Corporate revenues of $10 million, which were more than offset by charges of $18 million associated with the liquidation of the firm's special purpose acquisition company.

In light of the current environment, we are conducting cost-saving initiatives which are expected to result in the reduction of approximately 10% of our workforce over the course of 2023. Taking these actions resulted in an expense of $21 million in the first quarter and we expect an additional charge of approximately $95 million, which will be excluded from adjusted results.

OPERATING EXPENSES

Compensation and Benefits

In managing compensation and benefits expense, we focus on annual awarded compensation (cash compensation and benefits plus deferred incentive compensation with respect to the applicable year, net of estimated future forfeitures and excluding charges), a non-GAAP measure. We believe annual awarded compensation reflects the actual annual compensation cost more accurately than the GAAP measure of compensation cost, which includes applicable-year cash compensation and the amortization of deferred incentive compensation principally attributable to previous years’ deferred compensation. We believe that by managing our business using awarded compensation while targeting a consistent deferral policy, we can better manage our compensation costs, increase our flexibility in the future and build shareholder value over time.

For the first quarter of 2023, adjusted compensation and benefits expense1 was $399 million compared to $409 million for the first quarter of 2022. The adjusted compensation ratio for the first quarter of 2023 was 75.7%, compared to the first-quarter 2022 ratio of 58.5%. We currently expect our awarded compensation ratio for the full-year 2023 to be in the mid-60s percentage range.

Our goal remains to maintain a compensation-to-operating revenue ratio over the cycle in the mid- to high-50s percentage range on both an awarded and adjusted basis, while targeting a consistent deferral policy.

Non-Compensation Expense

For the first quarter of 2023, adjusted non-compensation expense1 was $142 million, 21% higher than the first quarter of 2022, primarily reflecting higher travel and business development and professional services expenses, as well as continued investments in technology.

The ratio of adjusted non-compensation expense to operating revenue was 27.0% for the first quarter of 2023, compared to 16.8% for the first quarter of 2022.

Our goal remains to maintain an adjusted non-compensation expense-to-operating revenue ratio over the cycle of 16% to 20%.

TAXES

Our operating loss for the first quarter of 2023 generated a tax benefit of $11 million on an adjusted basis.1

CAPITAL MANAGEMENT AND BALANCE SHEET

Our primary capital management goals include managing debt and returning capital to shareholders through dividends and share repurchases.

In the first quarter of 2023, Lazard returned $187 million to shareholders, which included: $43 million in dividends; $99 million in share repurchases of our common stock; and $45 million in satisfaction of employee tax obligations in lieu of share issuances upon vesting of equity grants.

In the first quarter of 2023, we repurchased 2.7 million shares. As of March 31, 2023, our remaining share repurchase authorization was $203 million.

On April 26, 2023, Lazard declared a quarterly dividend of $0.50 per share on its outstanding common stock. The dividend is payable on May 19, 2023, to stockholders of record on May 8, 2023.

Lazard’s financial position remains strong. As of March 31, 2023, our cash and cash equivalents were $597 million. Stockholders’ equity related to Lazard’s interests was $451 million.

ENDNOTES

1

A non-U.S. GAAP measure. See attached financial schedules and related notes for a detailed explanation of adjustments to corresponding U.S. GAAP results. We believe that presenting our results on an adjusted basis, in addition to the U.S. GAAP results, is the most meaningful and useful way to compare our operating results across periods.

 

2

First-quarter 2023 adjusted results1 exclude pre-tax charges of $10.7 million relating to expenses associated with senior management transition, $20.7 million relating to expenses associated with cost-saving initiatives, a benefit pursuant to tax receivable agreement obligation (“TRA”) of $40.4 million, and $19.1 million relating to certain asset impairment charges. On a U.S. GAAP basis, these resulted in a net credit of $0.8 million, or $0.01, per share, diluted, for the first quarter of 2023.

CONFERENCE CALL

Lazard will host a conference call at 8:00 a.m. ET on April 28, 2023, to discuss the company’s financial results for the first quarter of 2023. The conference call can be accessed via a live audio webcast available through Lazard’s Investor Relations website at www.lazard.com, or by dialing 1 800-225-9448 (toll-free, U.S. and Canada) or +1 203-518-9708 (outside of the U.S. and Canada), 15 minutes prior to the start of the call. Conference ID: LAZQ123.

A replay of the conference call will be available by 10:00 a.m. ET, April 28, 2023, via the Lazard Investor Relations website at www.lazard.com, or by dialing +1 800-723-5792 (toll-free, U.S. and Canada) or +1 402-220-2664 (outside of the U.S. and Canada).

ABOUT LAZARD

Lazard, one of the world's preeminent financial advisory and asset management firms, operates from 43 cities across 26 countries in North and South America, Europe, Asia and Australia. Celebrating its 175th year, the firm provides advice on mergers and acquisitions, capital markets and other strategic matters, restructuring and capital solutions, and asset management services to corporations, partnerships, institutions, governments and individuals. For more information on Lazard, please visit www.lazard.com. Follow Lazard at @Lazard.

Cautionary Note Regarding Forward-Looking Statements:

This press release contains forward-looking statements. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “target,” “goal,” or “continue,” and the negative of these terms and other comparable terminology. These forward-looking statements, which are subject to known and unknown risks, uncertainties and assumptions about us, may include projections of our future financial performance based on our growth strategies, business plans and initiatives and anticipated trends in our business. These forward-looking statements are only predictions based on our current expectations and projections about future events. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by these forward-looking statements.

These factors include, but are not limited to, those discussed in our Annual Report on Form 10-K under Item 1A “Risk Factors,” and also discussed from time to time in our reports on Forms 10-Q and 8-K, including the following:

  • A decline in general economic conditions or the global or regional financial markets;
  • A decline in our revenues, for example due to a decline in overall mergers and acquisitions (M&A) activity, our share of the M&A market or our assets under management (AUM);
  • Losses caused by financial or other problems experienced by third parties;
  • Losses due to unidentified or unanticipated risks;
  • A lack of liquidity, i.e., ready access to funds, for use in our businesses; and
  • Competitive pressure on our businesses and on our ability to retain and attract employees at current compensation levels.

Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. Neither we nor any other person assumes responsibility for the accuracy or completeness of any of these forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. We are under no duty to update any of these forward-looking statements after the date of this release to conform our prior statements to actual results or revised expectations and we do not intend to do so.

Lazard Ltd is committed to providing timely and accurate information to the investing public, consistent with our legal and regulatory obligations. To that end, Lazard and its operating companies use their websites, Lazard’s Twitter account (twitter.com/Lazard) and other social media sites to convey information about their businesses, including the anticipated release of quarterly financial results, quarterly financial, statistical and business-related information, and the posting of updates of assets under management in various mutual funds, hedge funds and other investment products managed by Lazard Asset Management LLC and Lazard Frères Gestion SAS. Investors can link to Lazard and its operating company websites through www.lazard.com.

LAZ-EPE

LAZARD LTD

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(U.S. GAAP)

   

 

 

Three Months Ended

 

% Change From

 

 

March 31,

 

December 31,

 

March 31,

 

December 31,

 

March 31,

($ in thousands, except per share data)

 

2023

 

2022

 

2022

 

2022

 

2022

 

 

 

 

 

 

 

 

 

 

 

Total revenue

 

$561,911

 

$731,860

 

$716,144

 

(23%)

 

(22%)

Interest expense

 

(19,475)

 

(19,471)

 

(21,252)

 

 

 

 

Net revenue

 

542,436

 

712,389

 

694,892

 

(24%)

 

(22%)

Operating expenses:

 

 

 

 

 

 

 

 

 

 

Compensation and benefits

 

449,967

 

474,843

 

396,841

 

(5%)

 

13%

 

 

 

 

 

 

 

 

 

 

 

Occupancy and equipment

 

31,773

 

30,907

 

31,239

 

 

 

 

Marketing and business development

 

22,762

 

26,674

 

14,123

 

 

 

 

Technology and information services

 

44,040

 

47,125

 

37,931

 

 

 

 

Professional services

 

24,326

 

21,292

 

16,029

 

 

 

 

Fund administration and outsourced services

 

26,576

 

24,614

 

29,703

 

 

 

 

Amortization and other acquisition-related costs

 

48

 

15

 

15

 

 

 

 

Other

 

20,303

 

14,988

 

9,283

 

 

 

 

Subtotal

 

169,828

 

165,615

 

138,323

 

3%

 

23%

Benefit pursuant to tax receivable agreement

 

(40,435)

 

(1,209)

 

 

 

 

 

Operating expenses

 

579,360

 

639,249

 

535,164

 

(9%)

 

8%

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

(36,924)

 

73,140

 

159,728

 

(150%)

 

(123%)

 

 

 

 

 

 

 

 

 

 

 

Provision (benefit) for income taxes

 

(21,725)

 

16,075

 

38,753

 

NM

 

(156%)

Net income (loss)

 

(15,199)

 

57,065

 

120,975

 

(127%)

 

(113%)

Net income attributable to noncontrolling interests

 

6,973

 

14,701

 

7,099

 

 

 

 

Net income (loss) attributable to Lazard Ltd

 

($22,172)

 

$42,364

 

$113,876

 

(152%)

 

(119%)

 

 

 

 

 

 

 

 

 

 

 

Attributable to Lazard Ltd Common Stockholders:

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

Basic

 

87,591,852

 

88,173,431

 

102,547,277

 

(1%)

 

(15%)

Diluted

 

87,591,852

 

94,185,566

 

108,186,642

 

(7%)

 

(19%)

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share:

 

 

 

 

 

 

 

 

 

 

Basic

 

($0.27)

 

$0.47

 

$1.09

 

(157%)

 

(125%)

Diluted

 

($0.27)

 

$0.44

 

$1.05

 

(161%)

 

(126%)

LAZARD LTD

UNAUDITED CONDENSED CONSOLIDATED

STATEMENT OF FINANCIAL CONDITION

(U.S. GAAP)

 

 

 

March 31,

 

December 31,

($ in thousands)

 

2023

 

2022

 

 

 

 

 

ASSETS

 

 

 

 

 

Cash and cash equivalents

 

$596,601

 

$1,234,773

Deposits with banks and short-term investments

 

522,560

 

779,246

Restricted cash

 

36,985

 

625,381

Receivables

 

698,127

 

652,758

Investments

 

741,868

 

698,977

Property

 

245,685

 

250,073

Goodwill and other intangible assets

 

394,260

 

377,330

Operating lease right-of-use assets

 

428,859

 

431,608

Deferred tax assets

 

367,655

 

407,657

Other assets

 

534,917

 

394,758

 

 

 

 

 

Total Assets

 

$4,567,517

 

$5,852,561

 

 

 

 

 

LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS & STOCKHOLDERS' EQUITY

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

Deposits and other customer payables

 

$697,088

 

$921,834

Accrued compensation and benefits

 

442,890

 

735,576

Operating lease liabilities

 

509,761

 

513,688

Tax receivable agreement obligation

 

118,563

 

191,189

Senior debt

 

1,688,335

 

1,687,714

Other liabilities

 

512,999

 

543,690

Total liabilities

 

3,969,636

 

4,593,691

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

89,472

 

583,471

 

 

 

 

 

Stockholders' equity

 

 

 

 

 

 

 

 

 

Preferred stock, par value $.01 per share

 

 

Common stock, par value $.01 per share

 

1,128

 

1,128

Additional paid-in capital

 

94,312

 

167,890

Retained earnings

 

1,604,650

 

1,676,713

Accumulated other comprehensive loss, net of tax

 

(282,957)

 

(295,854)

Subtotal

 

1,417,133

 

1,549,877

Class A common stock held by subsidiaries, at cost

 

(965,707)

 

(993,414)

Total Lazard Ltd stockholders' equity

 

451,426

 

556,463

Noncontrolling interests

 

56,983

 

118,936

Total stockholders' equity

 

508,409

 

675,399

 

 

 

 

 

Total liabilities, redeemable noncontrolling interests and stockholders' equity

 

$4,567,517

 

$5,852,561

LAZARD LTD

SELECTED SUMMARY FINANCIAL INFORMATION (a)

(Non-GAAP - unaudited)

   

 

 

Three Months Ended

 

% Change From

 

 

March 31,

 

December 31,

 

March 31,

 

December 31,

 

March 31,

($ in thousands, except per share data)

 

2023

 

2022

 

2022

 

2022

 

2022

 

 

 

 

 

 

 

 

 

 

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial Advisory

 

$273,861

 

$403,836

 

$388,130

 

(32%)

 

(29%)

Asset Management

 

264,645

 

258,618

 

311,781

 

2%

 

(15%)

Corporate

 

(11,488)

 

8,507

 

(1,276)

 

NM

 

NM

 

 

 

 

 

 

 

 

 

 

 

Operating revenue (b)

 

$527,018

 

$670,961

 

$698,635

 

(21%)

 

(25%)

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted compensation and benefits expense (c)

 

$399,090

 

$418,598

 

$408,702

 

(5%)

 

(2%)

Ratio of adjusted compensation to operating revenue

 

75.7 %

 

62.4 %

 

58.5 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-compensation expense (d)

 

$142,258

 

$141,843

 

$117,126

 

–%

 

21%

Ratio of non-compensation to operating revenue

 

27.0 %

 

21.1 %

 

16.8 %

 

 

 

 

 

Earnings:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) from operations (e)

 

($14,330)

 

$110,520

 

$172,807

 

(113%)

 

(108%)

Operating margin (f)

 

(2.7%)

 

16.5%

 

24.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted net income (loss) (g)

 

($22,948)

 

$67,130

 

$114,692

 

(134%)

 

(120%)

 

 

 

 

 

 

 

 

 

 

 

Diluted adjusted net income (loss) per share

 

($0.26)

 

$0.69

 

$1.05

 

(138%)

 

(125%)

 

 

 

 

 

 

 

 

 

 

 

Diluted weighted average shares (h)

 

87,591,852

 

97,222,787

 

109,178,143

 

(10%)

 

(20%)

 

 

 

 

 

 

 

 

 

 

 

Effective tax rate (i)

 

32.1 %

 

26.3 %

 

25.4 %

 

 

 

 

This presentation includes non-U.S. GAAP ("non-GAAP") measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Reconciliation of U.S. GAAP to Selected Summary Financial Information and Notes to Financial Schedules.

LAZARD LTD

ASSETS UNDER MANAGEMENT ("AUM")

(unaudited)

($ in millions)

   

 

 

As of

 

Variance

 

 

March 31,

 

December 31,

 

March 31,

 

 

 

1Q 2023 vs

 

 

2023

 

2022

 

2022

 

Qtr to Qtr

 

1Q 2022

 

 

 

 

 

 

 

 

 

 

 

Equity:

 

 

 

 

 

 

 

 

 

 

Emerging Markets

 

$23,692

 

$21,557

 

$26,575

 

9.9%

 

(10.8%)

Global

 

49,797

 

46,861

 

55,810

 

6.3%

 

(10.8%)

Local

 

49,887

 

47,504

 

53,832

 

5.0%

 

(7.3%)

Multi-Regional

 

55,252

 

51,473

 

64,810

 

7.3%

 

(14.7%)

Total Equity

 

178,628

 

167,395

 

201,027

 

6.7%

 

(11.1%)

Fixed Income:

 

 

 

 

 

 

 

 

 

 

Emerging Markets

 

9,164

 

8,944

 

11,997

 

2.5%

 

(23.6%)

Global

 

11,322

 

11,029

 

13,881

 

2.7%

 

(18.4%)

Local

 

6,002

 

5,352

 

5,652

 

12.1%

 

6.2%

Multi-Regional

 

18,973

 

18,061

 

13,454

 

5.0%

 

41.0%

Total Fixed Income

 

45,461

 

43,386

 

44,984

 

4.8%

 

1.1%

Alternative Investments

 

4,111

 

3,812

 

4,483

 

7.8%

 

(8.3%)

Other Alternative Investments

 

2,479

 

 

 

NM

 

NM

Private Equity

 

821

 

1,038

 

1,256

 

(20.9%)

 

(34.6%)

Cash Management

 

640

 

494

 

925

 

29.6%

 

(30.8%)

Total AUM

 

$232,140

 

$216,125

 

$252,675

 

7.4%

 

(8.1%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

 

 

 

Three Months Ended March 31,

 

 

 

December 31,

 

 

 

 

2023

 

2022

 

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

AUM - Beginning of Period

 

$216,125

 

$273,739

 

 

 

$273,739

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Flows (j)

 

2,999

 

(6,525)

 

 

 

(16,915)

 

 

Market and foreign exchange

 

 

 

 

 

 

 

 

 

 

appreciation (depreciation)

 

13,016

 

(14,539)

 

 

 

(40,699)

 

 

 

 

 

 

 

 

 

 

 

 

 

AUM - End of Period

 

$232,140

 

$252,675

 

 

 

$216,125

 

 

 

 

 

 

 

 

 

 

 

 

 

Average AUM

 

$226,849

 

$256,430

 

 

 

$227,444

 

 

 

 

 

 

 

 

 

 

 

 

 

% Change in average AUM

 

(11.5%)

 

 

 

 

 

 

 

 

 

Note: Average AUM generally represents the average of the monthly ending AUM balances for the period.

LAZARD LTD

RECONCILIATION OF U.S. GAAP TO SELECTED SUMMARY FINANCIAL INFORMATION (a)

(unaudited)

 

 

 

Three Months Ended

 

 

March 31,

 

December 31,

 

March 31,

($ in thousands, except per share data)

 

2023

 

2022

 

2022

 

 

 

 

 

 

 

Operating Revenue

Net revenue - U.S. GAAP Basis

 

$542,436

 

$712,389

 

$694,892

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

Revenue related to noncontrolling interests (k)

 

(10,823)

 

(16,771)

 

(10,795)

(Gains) losses related to Lazard Fund Interests ("LFI") and other similar arrangements

 

(16,453)

 

(21,340)

 

14,323

Distribution fees, reimbursable deal costs, bad debt expense and other (l)

 

(26,681)

 

(22,736)

 

(18,822)

Asset impairment charges (m)

 

19,129

 

 

Interest expense

 

19,410

 

19,419

 

19,037

 

 

 

 

 

 

 

Operating revenue, as adjusted (b)

 

$527,018

 

$670,961

 

$698,635

 

 

 

 

 

 

 

Compensation and Benefits Expense

Compensation and benefits expense - U.S. GAAP Basis

 

$449,967

 

$474,843

 

$396,841

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

(Charges) credits pertaining to LFI and other similar arrangements

 

(16,453)

 

(21,340)

 

14,323

Expenses associated with cost-saving initiatives (n)

 

(20,740)

 

 

Expenses associated with senior management transition (o)

 

(10,674)

 

(33,019)

 

Compensation related to noncontrolling interests (k)

 

(3,010)

 

(1,886)

 

(2,462)

 

 

 

 

 

 

 

Compensation and benefits expense, as adjusted (c)

 

$399,090

 

$418,598

 

$408,702

 

 

 

 

 

 

 

Non-Compensation Expense

Non-compensation expense - Subtotal - U.S. GAAP Basis

 

$169,828

 

$165,615

 

$138,323

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

Expenses related to office space reorganization (p)

 

 

(836)

 

(1,124)

Distribution fees, reimbursable deal costs, bad debt expense and other (l)

 

(26,681)

 

(22,736)

 

(18,822)

Amortization and other acquisition-related costs

 

(48)

 

(15)

 

(15)

Non-compensation expense related to noncontrolling interests (k)

 

(841)

 

(185)

 

(1,236)

 

 

 

 

 

 

 

Non-compensation expense, as adjusted (d)

 

$142,258

 

$141,843

 

$117,126

 

 

 

 

 

 

 

Pre-Tax Income and Earnings From Operations

Operating Income (Loss) - U.S. GAAP Basis

 

($36,924)

 

$73,140

 

$159,728

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

Benefit pursuant to tax receivable agreement obligation ("TRA") (q)

 

(40,435)

 

(1,209)

 

Asset impairment charges (m)

 

19,129

 

 

Expenses and losses associated with cost-saving initiatives (n)

 

20,740

 

 

Expenses associated with senior management transition (o)

 

10,674

 

33,019

 

Expenses related to office space reorganization (p)

 

 

836

 

1,124

Net income related to noncontrolling interests (k)

 

(6,973)

 

(14,701)

 

(7,099)

Pre-tax income (loss), as adjusted

 

(33,789)

 

91,085

 

153,753

Interest expense

 

19,410

 

19,419

 

19,037

Amortization and other acquisition-related costs

 

49

 

16

 

17

Earnings (loss) from operations, as adjusted (e)

 

($14,330)

 

$110,520

 

$172,807

 

 

 

 

 

 

 

Net Income attributable to Lazard Ltd

Net income (loss) attributable to Lazard Ltd - U.S. GAAP Basis

 

($22,172)

 

$42,364

 

$113,876

Adjustments:

 

 

 

 

 

 

Benefit pursuant to tax receivable agreement obligation ("TRA") (q)

 

(40,435)

 

(1,209)

 

Asset impairment charges (m)

 

19,129

 

 

Expenses and losses associated with cost-saving initiatives (n)

 

20,740

 

 

Expenses associated with senior management transition (o)

 

10,674

 

33,019

 

Expenses related to office space reorganization (p)

 

 

836

 

1,124

Tax benefit allocated to adjustments

 

(10,884)

 

(7,880)

 

(308)

 

 

 

 

 

 

 

Net income (loss), as adjusted (g)

 

($22,948)

 

$67,130

 

$114,692

 

 

 

 

 

 

 

Diluted Weighted Average Shares Outstanding

Diluted Weighted Average Shares Outstanding - U.S. GAAP Basis

 

87,591,852

 

94,185,566

 

108,186,642

Adjustment: participating securities including profits interest participation rights

 

 

3,037,221

 

991,501

 

 

 

 

 

 

 

Diluted Weighted Average Shares Outstanding, as adjusted (h)

 

87,591,852

 

97,222,787

 

109,178,143

 

 

 

 

 

 

 

Diluted net income (loss) per share:

 

 

 

 

 

 

U.S. GAAP Basis

 

($0.27)

 

$0.44

 

$1.05

Non-GAAP Basis, as adjusted

 

($0.26)

 

$0.69

 

$1.05

This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Notes to Financial Schedules.

See Notes to Financial Schedules

LAZARD LTD

RECONCILIATION OF NON-COMPENSATION U.S. GAAP TO ADJUSTED (a)

(unaudited)

   

 

 

Three Months Ended

 

 

March 31,

 

December 31,

 

March 31,

($ in thousands)

 

2023

 

2022

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-compensation expense - U.S. GAAP Basis:

 

 

 

 

 

 

Occupancy and equipment

 

$31,773

 

$30,907

 

$31,239

Marketing and business development

 

22,762

 

26,674

 

14,123

Technology and information services

 

44,040

 

47,125

 

37,931

Professional services

 

24,326

 

21,292

 

16,029

Fund administration and outsourced services

 

26,576

 

24,614

 

29,703

Amortization and other acquisition-related costs

 

48

 

15

 

15

Other

 

20,303

 

14,988

 

9,283

Non-compensation expense - Subtotal - U.S. GAAP Basis

 

$169,828

 

$165,615

 

$138,323

 

 

 

 

 

 

 

Non-compensation expense - Adjustments:

 

 

 

 

 

 

Occupancy and equipment (k) (p)

 

($61)

 

($828)

 

($1,183)

Marketing and business development (k) (l)

 

(2,728)

 

(3,656)

 

(1,225)

Technology and information services (k) (l)

 

(73)

 

(45)

 

(30)

Professional services (k) (l) (p)

 

(1,402)

 

(618)

 

(738)

Fund administration and outsourced services (k) (l)

 

(14,979)

 

(14,092)

 

(16,512)

Amortization and other acquisition-related costs

 

(48)

 

(15)

 

(15)

Other (k) (l) (p)

 

(8,279)

 

(4,518)

 

(1,494)

Subtotal Non-compensation adjustments

 

($27,570)

 

($23,772)

 

($21,197)

 

 

 

 

 

 

 

Non-compensation expense, as adjusted:

 

 

 

 

 

 

Occupancy and equipment

 

$31,712

 

$30,079

 

$30,056

Marketing and business development

 

20,034

 

23,018

 

12,898

Technology and information services

 

43,967

 

47,080

 

37,901

Professional services

 

22,924

 

20,674

 

15,291

Fund administration and outsourced services

 

11,597

 

10,522

 

13,191

Amortization and other acquisition-related costs

 

 

 

Other

 

12,024

 

10,470

 

7,789

Non-compensation expense, as adjusted (d)

 

$142,258

 

$141,843

 

$117,126

This presentation includes non-GAAP measures. Our non-GAAP measures are not meant to be considered in isolation or as a substitute for the corresponding U.S. GAAP measures and should be read only in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. For a detailed explanation of the adjustments made to the corresponding U.S. GAAP measures, see Notes to Financial Schedules.

See Notes to Financial Schedules

LAZARD LTD

Notes to Financial Schedules

(a)

 

Selected Summary Financial Information are non-GAAP measures. Lazard believes that presenting results and measures on an adjusted basis in conjunction with U.S. GAAP measures provides a meaningful and useful basis for comparison of its operating results across periods.

 

 

 

(b)

 

A non-GAAP measure which excludes (i) revenue related to noncontrolling interests (see (k) below), (ii) (gains) losses related to the changes in the fair value of investments held in connection with Lazard Fund Interests and other similar deferred compensation arrangements for which a corresponding equal amount is excluded from compensation & benefits expense, (iii) revenue related to distribution fees, reimbursable deal costs in accordance with the revenue recognition guidance, bad debt expense, and other (see (l) below), (iv) for the three month period ended March 31, 2023, asset impairment charges (see (m) below), and (v) interest expense primarily related to corporate financing activities.

 

 

 

(c)

 

A non-GAAP measure which excludes (i) (charges) credits related to the changes in the fair value of the compensation liability recorded in connection with Lazard Fund Interests and other similar deferred compensation arrangements, (ii) for the three month period ended March 31, 2023, expenses associated with cost-saving initiatives (see (n) below), (iii) for the three month periods ended March 31, 2023 and December 31, 2022, expenses associated with senior management transition (see (o) below), and (iv) compensation and benefits related to noncontrolling interests (see (k) below).

 

 

 

(d)

 

A non-GAAP measure which excludes (i) for the three month periods ended December 31, 2022 and March 31, 2022, expenses related to office space reorganization (see (p) below), (ii) expenses related to distribution fees, reimbursable deal costs in accordance with the revenue recognition guidance, bad debt expense, and other (see (l) below), (iii) amortization and other acquisition-related costs, and (iv) expenses related to noncontrolling interests (see (k) below).

 

 

 

(e)

 

A non-GAAP measure which excludes (i) for the three month periods ended March 31, 2023 and December 31, 2022, a benefit pursuant to tax receivable agreement obligation ("TRA") (see (q) below), (ii) for the three month period ended March 31, 2023, asset impairment charges (see (m) below), (iii) for the three month period ended March 31, 2023, expenses associated with cost-saving initiatives (see (n) below), (iv) for the three month periods ended March 31, 2023 and December 31, 2022, expenses associated with senior management transition (see (o) below), (v) for the three month periods ended December 31, 2022 and March 31, 2022, expenses related to office space reorganization (see (p) below), (vi) net revenue and expenses related to noncontrolling interests (see (k) below), (vii) interest expense primarily related to corporate financing activities, and (viii) amortization and other acquisition-related costs.

 

 

 

(f)

 

Represents earnings from operations as a percentage of operating revenue, and is a non-GAAP measure.

 

 

 

(g)

 

A non-GAAP measure which excludes (i) for the three month periods ended March 31, 2023 and December 31, 2022, a benefit pursuant to tax receivable agreement obligation ("TRA") (see (q) below), (ii) for the three month period ended March 31, 2023, asset impairment charges (see (m) below), (iii) for the three month period ended March 31, 2023, expenses associated with cost-saving initiatives (see (n) below), (iv) for the three month periods ended March 31, 2023 and December 31, 2022, expenses associated with senior management transition (see (o) below), and (v) for the three month periods ended December 31, 2022 and March 31, 2022, expenses related to office space reorganization (see (p) below), net of tax benefits.

 

 

 

(h)

 

A non-GAAP measure which includes units of the long-term incentive compensation program consisting of profits interest participation rights, which are equity incentive awards that, subject to certain conditions, may be exchanged for shares of our common stock. Certain profits interest participation rights and other participating securities may be excluded from the computation of outstanding stock equivalents for U.S. GAAP net income per share.

 

 

 

(i)

 

Effective tax rate is a non-GAAP measure based upon the U.S. GAAP rate with adjustments for the tax applicable to the non-GAAP adjustments to operating income, generally based upon the effective marginal tax rate in the applicable jurisdiction of the adjustments. The computation is based on a quotient, the numerator of which is the provision (benefit) for income taxes of ($10,841), $23,955, and $39,061 for the three month periods ended March 31, 2023, December 31, 2022, and March 31, 2022, respectively, and the denominator of which is pre-tax income (loss) of ($33,789), $91,085, and $153,753 for the three month periods ended March 31, 2023, December 31, 2022, and March 31, 2022, respectively.

 

 

 

(j)

 

Includes approximately $3.9 billion of net flows related to a wealth management acquisition.

 

 

 

(k)

 

Noncontrolling interests include revenue and expenses principally related to Edgewater, ESC Funds and a Special Purpose Acquisition Company.

 

 

 

(l)

 

Represents certain distribution, introducer and management fees paid to third parties and reimbursable deal costs for which an equal amount is excluded from both non-GAAP operating revenue and non-compensation expense, respectively, and excludes bad debt expense, which represents fees and other receivables that are deemed uncollectible.

 

 

 

(m)

 

Represents certain asset impairment charges.

 

 

 

(n)

 

Represents expenses associated with cost-saving initiatives, including a reduction in our workforce.

 

 

 

(o)

 

Represents expenses associated with senior management transition reflecting the departure of certain executive officers.

 

 

 

(p)

 

Represents building depreciation and other costs related to office space reorganization.

 

 

 

(q)

 

Pursuant to the periodic revaluation of the TRA liability and the assumptions reflected in the estimate, the revaluation had the effect of reducing the estimated liability under the TRA. As a result, the Company recorded a “benefit pursuant to tax receivable agreement” of $40,435 for the three month period ended March 31, 2023.

 

 

 

NM

 

Not meaningful

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.